STOCK TITAN

Enovis (ENOV) CEO receives 143,923-share RSU grant, total 246,676 held

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

McDonald Damien reported acquisition or exercise transactions in this Form 4 filing.

Enovis Corp Chief Executive Officer Damien McDonald received an equity award of 143,923 shares of common stock as a grant at no cash cost on the date of grant. This award consists of restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Following this grant, McDonald directly holds 246,676 shares of Enovis common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McDonald Damien

(Last) (First) (Middle)
C/O ENOVIS CORPORATION
2711 CENTERVILLE ROAD, SUITE 400

(Street)
WILMINGTON DE 19317

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 03/09/2026 A 143,923(1) A $0.00 246,676 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Brian P. Hanigan, attorney-in-fact 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovis (ENOV) CEO Damien McDonald report?

Damien McDonald reported receiving a grant of 143,923 shares of Enovis common stock as an equity award. The shares were acquired at a stated price of $0.0000 per share, indicating a compensation-related grant rather than an open-market purchase.

What type of shares did the Enovis (ENOV) CEO receive in this Form 4 filing?

The CEO received restricted stock units representing 143,923 shares of Enovis common stock, par value $0.001 per share. These units are subject to vesting conditions, rather than being fully unrestricted shares available for immediate sale upon grant.

How do the Enovis (ENOV) CEO’s restricted stock units vest over time?

The restricted stock units vest in three equal annual installments. Vesting begins on the first anniversary of the grant date, meaning one-third of the units vests each year over a three-year period, subject to the award’s terms.

How many Enovis (ENOV) shares does the CEO hold after this reported grant?

After this equity grant, Damien McDonald directly holds 246,676 shares of Enovis common stock. This total includes the newly granted 143,923 shares, which are structured as restricted stock units subject to the specified vesting schedule.

Was the Enovis (ENOV) CEO’s share grant an open-market purchase or compensation award?

The transaction was a compensation-related grant, classified as a grant, award, or other acquisition. The reported price per share was $0.0000, and the shares are in the form of restricted stock units that vest over three years.
Enovis Corp

NYSE:ENOV

View ENOV Stock Overview

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.34B
55.92M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON